Pediatric treatment satisfaction of medication measurement research: a systematic review_Chinese Journal of Evidence-Based Medicine

Authors：

YANG Mengting ^1,2,3,4,5 , JI Xiaorui ⁶ , YAN Weiyi ⁶ , ZHANG Shuya ⁶ , ZOU Kun ^1,2,3,4 , WAN Chaomin ^4,7 , JIA Zhijun ^1,2,3,4,6 , CHENG Guo ^4,7,8 ,  ZENG Linan ^1,2,3,4 ,  ZHANG Lingli ^1,2,3,4,9

1. Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
3. NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation, Chengdu 610041, P. R. China;
4. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, P. R. China;
5. West China School of Medicine, Sichuan University, Chengdu 610041, P. R. China;
6. West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China;
7. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
8. Laboratory of Molecular Translational Medicine, Center for Translational Medicine, Sichuan University, Chengdu 610041, P. R. China;
9. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding author：

ZENG Linan, Email: LinanZeng@scu.edu.cn; ZHANG Lingli, Email: zhanglingli@scu.edu.cn

Keywords：

Treatment satisfaction with medication; Pediatric; Scale; Systematic review; COSMIN; Measurement properties

DOI：

10.7507/1672-2531.202305134

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To systematically review the research on pediatric treatment satisfaction of medication (TS-M). Methods The PubMed, Embase, Cochrane Library, CBM, WanFang Data, VIP, CNKI databases and medical scale websites were electronically searched to collect studies on pediatric TS-M from inception to November 2022. Two reviewers independently screened literature, and extracted data. Using descriptive analysis, we comprehensively reviewed the TS-M assessment tool selected for the studies of children. We evaluated the methodological quality and measurement properties of existing TS-M scales for children using the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) assessment criteria. Results A total of 157 studies were included, including 150 pediatric studies using TS-M evaluation tools and 7 studies on the development and validation of TS-M scales for children, covering 7 specific TS-M scales for children. Our review revealed that 67.3% of the pediatric studies used unvalidated self-administered TS-M questionnaires or interviews, 24.7% used adult TS-M scales, and only 6.0% used two pediatric-specific TS-M scales. The results of the quality assessment indicated that the development quality of existing TS-M pediatric scales was considered "doubtful" or "inadequate", and the internal consistency was "sufficient" but the structural validity was probably "uncertain". High-quality research on the content validity, test-retest reliability and construct validity of the pediatric TS-M scale was still lacking. Conclusion Currently, the use of TS-M evaluation tools in pediatric studies has irrationalities: over 90% of pediatric studies use self-made questionnaires or adult scales to evaluate children's TS-M; and the existing pediatric TS-M scales globally have narrow applications, questionable development quality, and lack some measurement performance studies. Pediatric TS-M scales with a wide range of applications are lacking.

Citation： YANG Mengting, JI Xiaorui, YAN Weiyi, ZHANG Shuya, ZOU Kun, WAN Chaomin, JIA Zhijun, CHENG Guo, ZENG Linan, ZHANG Lingli. Pediatric treatment satisfaction of medication measurement research: a systematic review. Chinese Journal of Evidence-Based Medicine, 2024, 24(2): 183-191. doi: 10.7507/1672-2531.202305134 Copy

1.	Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health, 2004, 7(2): 204-215.
2.	Willke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials, 2004, 25(6): 535-552.
3.	U. S. Food and Drug Administration (FDA). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. MD: U. S. FDA, 2009.
4.	Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res, 2009, 18(1): 99-107.
5.	Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why. Qual Life Res, 2009, 18(1): 115-123.
6.	Cella D, Hahn EA, Jensen SE, et al. Patient-reported outcomes in performance measurement. RTI Press, 2015.
7.	Barbosa CD, Balp MM, Kulich K, et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence, 2012, 6: 39-48.
8.	Mahmoudian A, Zamani A, Tavakoli N, et al. Medication adherence in patients with hypertension: does satisfaction with doctor-patient relationship work. J Res Med Sci, 2017, 22: 48.
9.	Byun DW, Moon SH, Kim T, et al. Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea. J Bone Miner Metab, 2019, 37(3): 563-572.
10.	Prakash B. Patient satisfaction. J Cutan Aesthet Surg, 2010, 3(3): 151-155.
11.	Guglieri M, Bushby K, McDermott MP, et al. Effect of different corticosteroid dosing regimens on clinical outcomes in boys with duchenne muscular dystrophy: a randomized clinical trial. JAMA, 2022, 327(15): 1456-1468.
12.	Majewski S, Bhattacharya T, Asztalos M, et al. Sodium hypochlorite body wash in the management of Staphylococcus aureus-colonized moderate-to-severe atopic dermatitis in infants, children, and adolescents. Pediatr Dermatol, 2019, 36(4): 442-447.
13.	von Mackensen S, Shah J, Seifert W, et al. Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP. Haemophilia, 2019, 25(1): 45-53.
14.	Bryant PA, Katz NT. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review. Lancet Infect Dis, 2018, 18(2): e45-e54.
15.	Mueller-Godeffroy E, Vonthein R, Ludwig-Seibold C, et al. Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: the pumpkin multicenter randomized controlled trial. Pediatr Diabetes, 2018, 19(8): 1471-1480.
16.	degl' Innocenti A, Hassing LB, Ingelgård A, et al. Measuring treatment satisfaction. A review of randomized controlled drug trials. Clin Res Regul Aff, 2004, 21(1): 39-47.
17.	Johnston BC, Patrick DL, Devji T, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Chapter 18: patient-reported outcomes. Cochrane, 2021.
18.	郭秀花, 宁传华. 医学现场调查技术(案例版). 北京: 科学出版社, 2017.
19.	Bassel M, Hanson KA. Measuring treatment satisfaction and preference in patients with asthma and COPD: results of a targeted literature review. Value Health, 2016, 19(7): A557-A558.
20.	Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018, 27(5): 1147-1157.
21.	Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018, 27(5): 1171-1179.
22.	Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs) - user manual version 1.0. 2018.
23.	Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol, 2007, 60(1): 34-42.
24.	Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol, 2011, 64(4): 383-394.
25.	Clare B, Kate L, Alison W, et al. Development of the diabetes treatment satisfaction questionnaire (DTSQ) for teenagers and parents: the DTSQ-Teen and the DTSQ-Parent. Diabetologia, 2009, 52: S397.
26.	Görtz-Dorten A, Breuer D, Hautmann C, et al. What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD. A report on the development of a new rating scale. Eur Child Adolesc Psychiatry, 2011, 20(Suppl 2): S297-S307.
27.	Sampson MJ, Singh H, Dhatariya KK, et al. Psychometric validation and use of a novel diabetes in-patient treatment satisfaction questionnaire. Diabet Med, 2009, 26(7): 729-735.
28.	Rofail D, Gray R, Gournay K. The development and internal consistency of the satisfaction with Antipsychotic Medication Scale. Psychol Med, 2005, 35(7): 1063-1072.
29.	Rofail D, Abetz L, Viala M, et al. Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument. Value Health, 2009, 12(1): 109-117.
30.	Elalfy MS, Massoud W, Elsherif NH, et al. A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major. Pediatr Blood Cancer, 2012, 58(6): 910-915.
31.	Kempton C, Trask P, Parnes A, et al. Development and testing of the satisfaction questionnaire with intravenous or subcutaneous hemophilia injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVⅢ inhibitors. Haemophilia, 2021, 27(2): 221-228.
32.	国家卫生健康委. 卫健委印发《国际疾病分类第十一次修订本(ICD-11)中文版》. 医学信息学杂志, 2019, 40(2): 95.
33.	Churruca K, Pomare C, Ellis LA, et al. Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues. Health Expect, 2021, 24(4): 1015-1024.
34.	Elalfy MS, Adly AM, Wali Y, et al. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients. Eur J Haematol, 2015, 95(5): 411-420.
35.	Scalone L, Mantovani LG, Krol M, et al. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin, 2008, 24(7): 1905-1917.
36.	Porter J, Bowden DK, Economou M, et al. Health-related quality of life, treatment satisfaction, adherence and persistence in β-thalassemia and myelodysplastic syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial. Anemia, 2012, 2012: 297641.
37.	Bin-Abbas BS, Sakati NA, Al-Ashwal AA. Glycemic control and treatment satisfaction in Saudi diabetic children on insulin pump therapy. Ann Saudi Med, 2006, 26(3): 247-248.
38.	Frielitz FS, Müller-Godeffroy E, Hübner J, et al. Monthly video-consultation for children with type 1 diabetes using a continuous glucose monitoring system: design of ViDiKi, a multimethod intervention study to evaluate the benefit of telemedicine. J Diabetes Sci Technol, 2020, 14(1): 105-111.
39.	Troncone A, Chianese A, Cascella C, et al. Psychological outcomes in children and early adolescents with type 1 diabetes following pediatric diabetes summer camp: a 3-month follow-up study. Front Pediatr, 2021, 9: 650201.
40.	von Sengbusch S, Schneidewind J, Bokelmann J, et al. Monthly video consultation for children and adolescents with type 1 diabetes mellitus during the COVID-19 pandemic. Diabetes Res Clin Pract, 2022, 193: 110135.
41.	Rothenberger A, Becker A, Breuer D, et al. An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. Eur Child Adolesc Psychiatry, 2011, 20(Suppl 2): S257-S265.
42.	Haas J, Persson M, Brorsson AL, et al. Guided self-determination-young versus standard care in the treatment of young females with type 1 diabetes: study protocol for a multicentre randomized controlled trial. Trials, 2017, 18(1): 562.
43.	Haas J, Persson M, Hagström Toft E, et al. Treatment satisfaction correlated with glycaemic control and burden of diabetes in Swedish adolescents with type 1 diabetes. Acta Paediatr, 2020, 109(3): 573-580.
44.	Roh H, Kim B. A brief replication study comparing stimulants and non-stimulants for attention-deficit/hyperactivity disorder treatment with a focus on the compliance, efficacy, and satisfaction. Soa Chongsonyon Chongsin Uihak, 2021, 32(1): 10-16.
45.	Malia L, Laurich VM, Sturm JJ. Adverse events and satisfaction with use of intranasal midazolam for emergency department procedures in children. Am J Emerg Med, 2019, 37(1): 85-88.
46.	Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes, 2004, 2: 12.
47.	Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health, 2005, 8(Suppl 1): S9-S24.
48.	Bharmal M, Payne K, Atkinson MJ, et al. Validation of an abbreviated treatment satisfaction questionnaire for medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes, 2009, 7: 36.
49.	Pouwer F, Snoek FJ, van der Ploeg HM, et al. A comparison of the standard and the computerized versions of the well-being questionnaire (WBQ) and the diabetes treatment satisfaction questionnaire (DTSQ). Qual Life Res, 1998, 7(1): 33-38.
50.	Anderson RT, Skovlund SE, Marrero D, et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther, 2004, 26(4): 565-578.
51.	von Mackensen S, Gringeri A. Quality of life in hemophilia. Preedy VR, Watson RR, editors. Handbook of disease burdens and quality of life measures. New York: Springer, 2010: 1895-1920.
52.	Ruiz MA, Pardo A, Rejas J, et al. Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q). Value Health, 2008, 11(5): 913-926.
53.	Luo X, Cappelleri JC. A practical guide on incorporating and evaluating patient-reported outcomes in clinical trials. Clin Res Regul Aff, 2008, 25(4): 197-211.
54.	Pesudovs K, Burr JM, Harley C, et al. The development, assessment, and selection of questionnaires. Optom Vis Sci, 2007, 84(8): 663-674.
55.	Matza LS, Swensen AR, Flood EM, et al. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health, 2004, 7(1): 79-92.
56.	Eiser C, Varni JW. Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr, 2013, 172(10): 1299-1304.
57.	Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res, 2008, 17(6): 895-913.
58.	Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health, 2011, 14(8): 967-977.
59.	Lasch KE, Marquis P, Vigneux M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res, 2010, 19(8): 1087-1096.

1. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health, 2004, 7(2): 204-215.
2. Willke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials, 2004, 25(6): 535-552.
3. U. S. Food and Drug Administration (FDA). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. MD: U. S. FDA, 2009.
4. Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res, 2009, 18(1): 99-107.
5. Greenhalgh J. The applications of PROs in clinical practice: what are they, do they work, and why. Qual Life Res, 2009, 18(1): 115-123.
6. Cella D, Hahn EA, Jensen SE, et al. Patient-reported outcomes in performance measurement. RTI Press, 2015.
7. Barbosa CD, Balp MM, Kulich K, et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence, 2012, 6: 39-48.
8. Mahmoudian A, Zamani A, Tavakoli N, et al. Medication adherence in patients with hypertension: does satisfaction with doctor-patient relationship work. J Res Med Sci, 2017, 22: 48.
9. Byun DW, Moon SH, Kim T, et al. Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea. J Bone Miner Metab, 2019, 37(3): 563-572.
10. Prakash B. Patient satisfaction. J Cutan Aesthet Surg, 2010, 3(3): 151-155.
11. Guglieri M, Bushby K, McDermott MP, et al. Effect of different corticosteroid dosing regimens on clinical outcomes in boys with duchenne muscular dystrophy: a randomized clinical trial. JAMA, 2022, 327(15): 1456-1468.
12. Majewski S, Bhattacharya T, Asztalos M, et al. Sodium hypochlorite body wash in the management of Staphylococcus aureus-colonized moderate-to-severe atopic dermatitis in infants, children, and adolescents. Pediatr Dermatol, 2019, 36(4): 442-447.
13. von Mackensen S, Shah J, Seifert W, et al. Health-related quality of life in paediatric haemophilia B patients treated with rIX-FP. Haemophilia, 2019, 25(1): 45-53.
14. Bryant PA, Katz NT. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review. Lancet Infect Dis, 2018, 18(2): e45-e54.
15. Mueller-Godeffroy E, Vonthein R, Ludwig-Seibold C, et al. Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: the pumpkin multicenter randomized controlled trial. Pediatr Diabetes, 2018, 19(8): 1471-1480.
16. degl' Innocenti A, Hassing LB, Ingelgård A, et al. Measuring treatment satisfaction. A review of randomized controlled drug trials. Clin Res Regul Aff, 2004, 21(1): 39-47.
17. Johnston BC, Patrick DL, Devji T, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Chapter 18: patient-reported outcomes. Cochrane, 2021.
18. 郭秀花, 宁传华. 医学现场调查技术(案例版). 北京: 科学出版社, 2017.
19. Bassel M, Hanson KA. Measuring treatment satisfaction and preference in patients with asthma and COPD: results of a targeted literature review. Value Health, 2016, 19(7): A557-A558.
20. Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018, 27(5): 1147-1157.
21. Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018, 27(5): 1171-1179.
22. Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs) - user manual version 1.0. 2018.
23. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol, 2007, 60(1): 34-42.
24. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol, 2011, 64(4): 383-394.
25. Clare B, Kate L, Alison W, et al. Development of the diabetes treatment satisfaction questionnaire (DTSQ) for teenagers and parents: the DTSQ-Teen and the DTSQ-Parent. Diabetologia, 2009, 52: S397.
26. Görtz-Dorten A, Breuer D, Hautmann C, et al. What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD. A report on the development of a new rating scale. Eur Child Adolesc Psychiatry, 2011, 20(Suppl 2): S297-S307.
27. Sampson MJ, Singh H, Dhatariya KK, et al. Psychometric validation and use of a novel diabetes in-patient treatment satisfaction questionnaire. Diabet Med, 2009, 26(7): 729-735.
28. Rofail D, Gray R, Gournay K. The development and internal consistency of the satisfaction with Antipsychotic Medication Scale. Psychol Med, 2005, 35(7): 1063-1072.
29. Rofail D, Abetz L, Viala M, et al. Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument. Value Health, 2009, 12(1): 109-117.
30. Elalfy MS, Massoud W, Elsherif NH, et al. A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major. Pediatr Blood Cancer, 2012, 58(6): 910-915.
31. Kempton C, Trask P, Parnes A, et al. Development and testing of the satisfaction questionnaire with intravenous or subcutaneous hemophilia injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVⅢ inhibitors. Haemophilia, 2021, 27(2): 221-228.
32. 国家卫生健康委. 卫健委印发《国际疾病分类第十一次修订本(ICD-11)中文版》. 医学信息学杂志, 2019, 40(2): 95.
33. Churruca K, Pomare C, Ellis LA, et al. Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues. Health Expect, 2021, 24(4): 1015-1024.
34. Elalfy MS, Adly AM, Wali Y, et al. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients. Eur J Haematol, 2015, 95(5): 411-420.
35. Scalone L, Mantovani LG, Krol M, et al. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin, 2008, 24(7): 1905-1917.
36. Porter J, Bowden DK, Economou M, et al. Health-related quality of life, treatment satisfaction, adherence and persistence in β-thalassemia and myelodysplastic syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial. Anemia, 2012, 2012: 297641.
37. Bin-Abbas BS, Sakati NA, Al-Ashwal AA. Glycemic control and treatment satisfaction in Saudi diabetic children on insulin pump therapy. Ann Saudi Med, 2006, 26(3): 247-248.
38. Frielitz FS, Müller-Godeffroy E, Hübner J, et al. Monthly video-consultation for children with type 1 diabetes using a continuous glucose monitoring system: design of ViDiKi, a multimethod intervention study to evaluate the benefit of telemedicine. J Diabetes Sci Technol, 2020, 14(1): 105-111.
39. Troncone A, Chianese A, Cascella C, et al. Psychological outcomes in children and early adolescents with type 1 diabetes following pediatric diabetes summer camp: a 3-month follow-up study. Front Pediatr, 2021, 9: 650201.
40. von Sengbusch S, Schneidewind J, Bokelmann J, et al. Monthly video consultation for children and adolescents with type 1 diabetes mellitus during the COVID-19 pandemic. Diabetes Res Clin Pract, 2022, 193: 110135.
41. Rothenberger A, Becker A, Breuer D, et al. An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. Eur Child Adolesc Psychiatry, 2011, 20(Suppl 2): S257-S265.
42. Haas J, Persson M, Brorsson AL, et al. Guided self-determination-young versus standard care in the treatment of young females with type 1 diabetes: study protocol for a multicentre randomized controlled trial. Trials, 2017, 18(1): 562.
43. Haas J, Persson M, Hagström Toft E, et al. Treatment satisfaction correlated with glycaemic control and burden of diabetes in Swedish adolescents with type 1 diabetes. Acta Paediatr, 2020, 109(3): 573-580.
44. Roh H, Kim B. A brief replication study comparing stimulants and non-stimulants for attention-deficit/hyperactivity disorder treatment with a focus on the compliance, efficacy, and satisfaction. Soa Chongsonyon Chongsin Uihak, 2021, 32(1): 10-16.
45. Malia L, Laurich VM, Sturm JJ. Adverse events and satisfaction with use of intranasal midazolam for emergency department procedures in children. Am J Emerg Med, 2019, 37(1): 85-88.
46. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes, 2004, 2: 12.
47. Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health, 2005, 8(Suppl 1): S9-S24.
48. Bharmal M, Payne K, Atkinson MJ, et al. Validation of an abbreviated treatment satisfaction questionnaire for medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes, 2009, 7: 36.
49. Pouwer F, Snoek FJ, van der Ploeg HM, et al. A comparison of the standard and the computerized versions of the well-being questionnaire (WBQ) and the diabetes treatment satisfaction questionnaire (DTSQ). Qual Life Res, 1998, 7(1): 33-38.
50. Anderson RT, Skovlund SE, Marrero D, et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther, 2004, 26(4): 565-578.
51. von Mackensen S, Gringeri A. Quality of life in hemophilia. Preedy VR, Watson RR, editors. Handbook of disease burdens and quality of life measures. New York: Springer, 2010: 1895-1920.
52. Ruiz MA, Pardo A, Rejas J, et al. Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q). Value Health, 2008, 11(5): 913-926.
53. Luo X, Cappelleri JC. A practical guide on incorporating and evaluating patient-reported outcomes in clinical trials. Clin Res Regul Aff, 2008, 25(4): 197-211.
54. Pesudovs K, Burr JM, Harley C, et al. The development, assessment, and selection of questionnaires. Optom Vis Sci, 2007, 84(8): 663-674.
55. Matza LS, Swensen AR, Flood EM, et al. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health, 2004, 7(1): 79-92.
56. Eiser C, Varni JW. Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr, 2013, 172(10): 1299-1304.
57. Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res, 2008, 17(6): 895-913.
58. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health, 2011, 14(8): 967-977.
59. Lasch KE, Marquis P, Vigneux M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res, 2010, 19(8): 1087-1096.

Chinese Journal of Evidence-Based Medicine

Pediatric treatment satisfaction of medication measurement research: a systematic review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content